TC
KROS icon

Telemus Capital’s Keros Therapeutics KROS Stock Holding History

Telemus Capital’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$775K – 408
2020
Q3 		$775K Buy
15,000
+5,000
+50% +$258K 0.06% 232
2020
Q2 		$328K Buy
+10,000
New +$328K 0.03% 329